Anterix Inc. — Director's Dealing 2022

Jun 9, 2022

SEC Form 4/A — Form 4/A

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2021-09-07

Reporting Person: OBRIEN MORGAN E (Director, Executive Chairman)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-07	Stock Option (Right to Buy)	$60.92	A	65768	Acquired	2031-09-07	Common Stock (65768)	Direct

Footnotes

F1: The prior Form 4 incorrectly reported the option grant for 65,595 shares.

F2: 33 1/3% of the option shares vest and become exercisable on September 7, 2022 with the remaining shares vesting in 2 equal annual installments thereafter.